Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size study, By Type (Autologous Stem Cells, Autologous Non-Stem Cells), By Product (Blood Pressure (BP) Monitoring Devices, Pulmonary Pressure Monitoring Devices, Intracranial Pressure (ICP) Monitoring Devices), By Application (Neurodegenerative Disorders, Autoimmune Diseases, Cancer and Tumors, Cardiovascular Diseases), By End-User (Hospitals, Ambulatory Surgical Center), and Regional Forecasts 2022-2028
- BIZ4950409
- 200 Pages
- March 2022
- Pharmaceuticals
Autologous stem-cell transplantation is a form of transplant in which stem cells or homogenous cells are removed from an individual’s body, accumulated, and then returned to the same person. It is also known as autogenous stem-cell transplantation or autogenic or auto-SCT. The two common forms of stem cell transplantation are allogenic stem cell transplantation and autologous stem cell transplantation. The increasing prevalence of cancer and diabetes in all age groups, rising geriatric population, increasing demand for the autologous stem cell and non-stem cell primarily based therapies, execution of several favorable government policies are the primary factors that may accelerate the market demand. For instance, according to the National Cancer Institute, there were nearly 16.9 million cancer survivors in the United States, which is anticipated to reach 22.2 million by 2030. Additionally, the increasing number of research and development activities and vast untapped markets in developing economies are further propelling market growth around the world. However, the shortage of skilled professionals hinders the market growth over the forecast period of 2022-2028. Also, the introduction of novel autologous stem cell-based therapies in regenerative medicine is anticipated to act as a catalyzing factor for the market demand during the forecast period.
The key regions considered for the global Autologous Stem Cell and Non-Stem Cell-Based Therapies market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the availability of well-developed healthcare infrastructure for the treatment of many infectious disorders and minimizing risks involved with the therapy. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as rising investment for advancing healthcare facilities, as well as the imposition of favorable reimbursement policies, would create lucrative growth prospects for the Autologous Stem Cell and Non-Stem Cell-Based Therapies market across the Asia-Pacific region.
Major market players included in this report are:
Antria (CRO)
Bioheart
Brainstorm Cell Therapeutics
Cytori
Dendreon Corporation
Fibrocell
Genesis Biopharma
Georgia Health Sciences University
Neostem
Opexa Therapeutics
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Autologous Stem Cells
Autologous Non-Stem Cells
By Product:
Blood Pressure (BP) Monitoring Devices
Pulmonary Pressure Monitoring Devices
Intracranial Pressure (ICP) Monitoring Devices
By Application:
Neurodegenerative Disorders
Autoimmune Diseases
Cancer And Tumors
Cardiovascular Diseases
By End-User:
Hospitals
Ambulatory Surgical Center
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, by Type, 2020-2028 (USD Billion)
1.2.3. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, by Product, 2020-2028 (USD Billion)
1.2.4. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, by Application, 2020-2028 (USD Billion)
1.2.5. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, by End-User, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Dynamics
3.1. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of targeted diseases
3.1.1.2. Growing geriatric population
3.1.2. Market Challenges
3.1.2.1. Lack of skilled professionals
3.1.3. Market Opportunities
3.1.3.1. Introduction of novel autologous stem cell-based therapies in regenerative medicine
Chapter 4. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, by Type
6.1. Market Snapshot
6.2. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Type, Performance - Potential Analysis
6.3. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Estimates & Forecasts by Type 2019-2028 (USD Billion)
6.4. Autologous Stem Cell and Non-Stem Cell Based Therapies Market, Sub Segment Analysis
6.4.1. Autologous Stem Cells
6.4.2. Autologous Non-Stem Cells
Chapter 7. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, by Product
7.1. Market Snapshot
7.2. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Product, Performance - Potential Analysis
7.3. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Estimates & Forecasts by Product 2019-2028 (USD Billion)
7.4. Autologous Stem Cell and Non-Stem Cell Based Therapies Market, Sub Segment Analysis
7.4.1. Blood Pressure (BP) Monitoring Devices
7.4.2. Pulmonary Pressure Monitoring Devices
7.4.3. Intracranial Pressure (ICP) Monitoring Devices
Chapter 8. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, by Application
8.1. Market Snapshot
8.2. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by Application, Performance - Potential Analysis
8.3. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Estimates & Forecasts by Application 2019-2028 (USD Billion)
8.4. Autologous Stem Cell and Non-Stem Cell Based Therapies Market, Sub Segment Analysis
8.4.1. Neurodegenerative Disorders
8.4.2. Autoimmune Diseases
8.4.3. Cancer And Tumors
8.4.4. Cardiovascular Diseases
Chapter 9. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, by End-User
9.1. Market Snapshot
9.2. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by End-User, Performance - Potential Analysis
9.3. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Estimates & Forecasts by End-User 2019-2028 (USD Billion)
9.4. Autologous Stem Cell and Non-Stem Cell Based Therapies Market, Sub Segment Analysis
9.4.1. Hospitals
9.4.2. Ambulatory Surgical Center
Chapter 10. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, Regional Analysis
10.1. Autologous Stem Cell and Non-Stem Cell Based Therapies Market, Regional Market Snapshot
10.2. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.2.1. U.S. Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.2.1.1. Type estimates & forecasts, 2019-2028
10.2.1.2. Product estimates & forecasts, 2019-2028
10.2.1.3. Application estimates & forecasts, 2019-2028
10.2.1.4. End-User estimates & forecasts, 2019-2028
10.2.2. Canada Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.3. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Snapshot
10.3.1. U.K. Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.3.2. Germany Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.3.3. France Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.3.4. Spain Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.3.5. Italy Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.3.6. Rest of Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.4. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Snapshot
10.4.1. China Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.4.2. India Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.4.3. Japan Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.4.4. Australia Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.4.5. South Korea Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.4.6. Rest of Asia Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.5. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Snapshot
10.5.1. Brazil Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.5.2. Mexico Autologous Stem Cell and Non-Stem Cell Based Therapies Market
10.6. Rest of The World Autologous Stem Cell and Non-Stem Cell Based Therapies Market
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Antria (CRO)
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Bioheart
11.2.3. Brainstorm Cell Therapeutics
11.2.4. Cytori
11.2.5. Dendreon Corporation
11.2.6. Fibrocell
11.2.7. Genesis Biopharma
11.2.8. Georgia Health Sciences University
11.2.9. Neostem
11.2.10. Opexa Therapeutics
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
TABLE 1. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market, report scope
TABLE 2. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by Region 2019-2028 (USD Billion)
TABLE 3. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by Type 2019-2028 (USD Billion)
TABLE 4. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by Product 2019-2028 (USD Billion)
TABLE 5. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by Application 2019-2028 (USD Billion)
TABLE 6. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by End-User 2019-2028 (USD Billion)
TABLE 7. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 8. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 9. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 10. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 11. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 12. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 13. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 14. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 15. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 16. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 17. U.S. Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 18. U.S. Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 19. U.S. Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 20. Canada Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 21. Canada Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 22. Canada Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 23. UK Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 24. UK Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 25. UK Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 26. Germany Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 27. Germany Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 28. Germany Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 29. RoE Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 30. RoE Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 31. RoE Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 32. China Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 33. China Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 34. China Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 35. India Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 36. India Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 37. India Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 38. Japan Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 39. Japan Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 40. Japan Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 41. RoAPAC Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 42. RoAPAC Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 43. RoAPAC Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 44. Brazil Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 45. Brazil Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 46. Brazil Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 47. Mexico Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 48. Mexico Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 49. Mexico Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 50. RoLA Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 51. RoLA Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 52. RoLA Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 53. Row Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 54. Row Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 55. Row Autologous Stem Cell and Non-Stem Cell Based Therapies Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 56. List of secondary sources, used in the study of global Autologous Stem Cell and Non-Stem Cell Based Therapies Market
TABLE 57. List of primary sources, used in the study of global Autologous Stem Cell and Non-Stem Cell Based Therapies Market
TABLE 58. Years considered for the study
TABLE 59. Exchange rates considered
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
